Elevated Ki-67 (MIB-1) expression as an independent predictor for unfavorable pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with localized prostate cancer: A propensity score matched study-Reference-Cited by-同舟云学术

Elevated Ki-67 (MIB-1) expression as an independent predictor for unfavorable pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with localized prostate cancer: A propensity score matched study

Published:2019-11-07 Issue:11 Volume:14 Page:e0224671
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Byun Seok-Soo,Lee Minseung,Hong Sung Kyu,Lee Hakmin^ORCID

Funder

National Research Foundation of Korea

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. Cancer statistics, 2012;R Siegel;CA Cancer J Clin,2012

2. Active surveillance for intermediate-risk prostate cancer;MA Dall’Era;Prostate Cancer Prostatic Dis. Prostate Cancer Prostatic Dis,2017

3. Novel diagnostic biomarkers for prostate cancer;CO Madu;J Cancer,2010

4. The Ki‐67 protein: from the known and the unknown;T Scholzen;J Cell Physiol,2000

5. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy;MC Bettencourt;J Urol,1996

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive factors associated with differential pathologic response to neoadjuvant chemohormonal therapy in high-risk localized prostate cancer;Urologic Oncology: Seminars and Original Investigations;2023-08

2. Metastatic prostate cancer diagnosed by fine‐needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlates;Cancer Cytopathology;2022-10-20

3. Tumour microenvironment and focal therapy for prostate cancer;Current Opinion in Urology;2022-05

4. Preoperative histogram parameters of dynamic contrast‐enhanced MRI as a potential imaging biomarker for assessing the expression of Ki‐67 in prostate cancer;Cancer Medicine;2021-06-12

5. Neural network modeling for prediction of recurrence, progression, and hormonal non-remission in patients following resection of functional pituitary adenomas;Pituitary;2021-02-02